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Background
Pacemaker/AICD imaging is infrequently performed on
patients in an MRI environment. When the risk justifies
the end, however, consideration to perform ‘high-risk’
scanning can be made on a case-by-case basis but typically
with trepidation. However, an important issue has sur-
faced, “Is the MRI scan adding valuable and irrefutable
information to warrant such risk?
Methods
Over 3 years, 48 patients were imaged via MRI/CMR (1.5T
GE, Milwaukee, WI). Specifically: 8 AICD, 7 AICD/PM, 2
retained lead, 2 REVO and 29 dual chamber PM. Specific
criteria were followed for all pts to objectively define
whether final diagnosis provided additional information
towards pt care. A checklist of 3 questions was answered
following scan interpretation by both the technologist and
performing MRI physician: 1) Did the diagnosis change?
2) Did the MRI provide additional information to the
existing diagnosis? 3) Did patient management change? If
‘Yes’ was answered to any of the above questions, it was
considered that the MRI scan was of value to patient
diagnosis and/or therapy.
Results
All patients completed the procedure with no death, VT/
VF, power-on-reset or adverse events. The PM/AICD was
interrogated after the scan by EP/cardiologist to determine
changes in impedance, amplitude or threshold. No clini-
cally meaningful changes occured and no post-procedure
revisions to generator/lead or parameters were required.
Avg MRI: 20 ± 55 min. Regarding the population, 36/48
(75%) were neurology/neurosurgery and 12(25%) were
cardiac/vascular cases. After reviewing the 36 neurology
cases and comparing the results from prior studies (CT,
angio, EEG and/or myelogram), 16/35 (45%) MRIs not
only provided additional information but changed the
original diagnosis and, in turn, the course of medical
treatment. In 8 pts (22%), the MRI provided additional
information to the original diagnosis. Thus, a total of
24 pts (67%) demonstrated MRI scanning was of value
to the final diagnosis. In 12/36(33%) pts, MRI did not
provide further information but confirmed original
diagnosis. The 12 cardiac cases were also compared to
prior studies (catheterization, TEE, TTE and/or stress)
and in 4 pts (33%), the MRI provided additional infor-
mation to change the original diagnosis and also pt
management. The remaining 8 (67%) revealed extra
information was gathered via CMR. In essence, 100%
of the cardiac population benefited by having a CMR
exam performed.
Conclusions
The use of PM/AICD imaging in MRI remains contro-
versial but as the lead/generator technology has
improved and increased confidence in its use is found.
We show that MRI/CMR procedures on carefully
selected patients with PM/AICDs are beneficial and
substantially add valuable, often irrefutable informa-
tion to pt diagnosis and subsequent management
We propose that not only are PM/AICDs safe when
imaged properly but potentially no longer ‘forbidden’
in the MRI environment. Moreover, there can be
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